Although the implication for compensatory changes is still unclear, evidence suggests that there are two main potential mechanisms contribute to compensation: PET studies suggesting that compensatory upregulation of D2-receptors and enzyme dopa decarboxylase were found in early untreated PD patients (Antonini et al., 1994; Kaasinen et al., 2000). This evidence concerns the gene DDC and Parkinson disease.